Research Article
Nanosuspension: An Emerging Trend for Bioavailability Enhancement of Etodolac
Figure 6
(a) Dissolution profiles of ET nanosuspensions prepared by antisolvent method in phosphate buffer pH 6.8. not significant one-way ANOVA significant two-way ANOVA. (b) Dissolution profiles of ET nanosuspensions prepared by antisolvent method in phosphate buffer pH 6.8. Not significant one way ANOVA but significant two-way ANOVA .
(a) |
(b) |